-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
Arginine therapy: a potential treatment for sickle cell pain
News and Views: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation